H.R.806: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

About This Bill

Bill Summary

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.

(Source: Library of Congress)

Bill Actions

Date Description
Referred to the House Committee on Energy and Commerce.
Feb. 5, 2007

Introduced in the House by Jo Ann Emerson (R-Mo.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page